200 likes | 232 Views
TASO Soroti Region VL-EID-TB Performance Dr Ninsiima Muhairwe Francis Ocen. Presentation outline. VL coverage by district Trends of VL coverage VL suppression & Rejection rates VL QI projects running by district, tested changes and outcomes Next steps EID Cascade TB/HIV management.
E N D
TASO Soroti Region VL-EID-TB Performance Dr Ninsiima Muhairwe Francis Ocen
Presentation outline • VL coverage by district • Trends of VL coverage • VL suppression & Rejection rates • VL QI projects running by district, tested changes and outcomes • Next steps • EID Cascade • TB/HIV management TASO
Strategies • Activation of VL teams • Re-organization of VL teams. • Monthly data review – dash board • Targeted CMEs. • IAC forms, Non-Suppression register • Counselors – HV sites • Weekly tracking of rejection, causes • Non-Supression clinics • Next steps • Stake holders meeting • Increased involvement of DHT • Targeted psychosocial support • Uphold the current strategies TASO
Running Viral load QI Projects Created a non-suppressed clinic Creation of a viral load committee TASO
Interventions employed to improve EID • Functionalizing Testing Point at ANC/MCH • Notification for results that are not received within 3weeks. • Structuring of mothers next appoint to expected EID return date. • Developed data base that captures the HEI date of birth and expected dates for EID testing. • Integrated EID into EPI outreach static and outreach. • Used reminder stickers for 1st, 2nd and 3rd PCR • Improving outcomes for 24 months cohorts • Intensified referral and tracking of LTFU-MBPs • Integrated of EID into EPI outreach/ static • Assigned mentors to specific facilities to follow-up MBPs. • Scaled up use of reminder stickers for 1st, 2nd and 3rd PCR and 18 months rapid test. • Monthly reviews of retention and birth cohorts for MBPs. TASO
TB SCREENING IN ART TASO
COP TB_STAT PERFORMANCE ACHIEVEMENT • Quarter target achievement of 96% • Cumulative 63% annual target achievement of the expected 75% by 3rd QTR • Need 794 cases to 100% annual target
GeneXpert Utilization from the seven hubs The chart illustrates GeneXpert utilization and this has greatly improved case finding in the region TASO
TB PREV Indicator performance April-June 2018 • Improvement from 16% in Jan to March 2018 to 24% in April to June 2018 • Affected by unreliable stock levels and knowledge gap • Site reorientation carried out for 11 sites in May 2018 TASO
TB Treatment Success all forms Treatment success has been poor because of suboptimal tracking systems at facility level. Facilities are now employing the VHTs in tracking lost TB patients TASO